ERS guidelines on treatment of sarcoidosis

D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany)

Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis
Number: 0
Disease area: Interstitial lung diseases

Slide presentationWebcast

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany). ERS guidelines on treatment of sarcoidosis. ERS webinar 2021: ERS guidelines on treatment of sarcoidosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001



Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

COVID-19: Current Challenges in ILD
Source: ERS webinar 2020: COVID-19: Current Challenges in ILD
Year: 2020


Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019



A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Delay in diagnosis of interstitial lung diseases (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Clinical case on ILD: a pulmonary case with many faces: not only interstitium
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007

Interstitial lung disease in elderly subjects
Source: Eur Respir Mon; 2009: 43: 150–162
Year: 2009

Rare pneumoconioses
Source: Annual Congress 2005 - Update on orphan lung diseases
Year: 2005

Interstitial fibrosis with a nodule
Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session
Year: 2007

Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Rare interstitial lung diseases of environmental origin
Source: Eur Respir Mon 2011; 54: 301-316
Year: 2011